Sirius Therapeutics Co., Ltd.

This study tests an investigational drug called SRSD107 in people with chronic coronary artery disease or peripheral arterial disease. The goal is to see if it safely reduces a protein involved in blood clotting, which may lower the risk of dangerous clots. About 104 adults will …

This study tests an experimental drug called SRSD107 to see if it can prevent blood clots in people having knee replacement surgery. About 450 adults aged 60 to 80 will receive either SRSD107 or the standard blood thinner enoxaparin. The goal is to compare how well each drug prev…

This study tests a new medicine called SRSD216, given as a shot under the skin, for people with high levels of lipoprotein(a) — a genetic risk factor for heart disease. The trial has two parts and will enroll 84 adults to check the drug's safety and how the body processes it. Par…